Johnson & Johnson vs Pfizer
JNJJohnson & Johnsonvs
PFEPfizer Inc.- Johnson & Johnson: Diversified pharma/medical devices giant. Slow steady grower with a strong dividend.
- Pfizer: US pharma giant. Post-COVID slump - they're hunting for the next blockbuster franchise.
- Over the past five years Johnson & Johnson stock returned +73% versus -20% for Pfizer, in USD. Past performance is not a guide to the future.
- They compete in the same space (Pharma & biotech), so many investors simply own both through a broad index fund instead of picking a winner.
Shown in USD. Past performance is not a reliable guide to future results.
- Country
- 🇺🇸 United States
- 🇺🇸 United States
- Industry
- Pharma & biotech
- Pharma & biotech
- 1Y return (USD)
- +56.3%
- +10.0%
- 3Y return (USD)
- +72.3%
- -17.5%
- 5Y return (USD)
- +72.9%
- -19.7%
- Trades in
- USD
- USD
Johnson & JohnsonJNJDiversified pharma/medical devices giant. Slow steady grower with a strong dividend.
See full Johnson & Johnson details →PfizerPFEUS pharma giant. Post-COVID slump - they're hunting for the next blockbuster franchise.
See full Pfizer details →
Available on Interactive Brokers
Buy Johnson & Johnson, Pfizer and thousands of other stocks worldwide on Interactive Brokers.
Frequently asked questions
Which performed better, Johnson & Johnson or Pfizer?
Over the past five years Johnson & Johnson stock returned +73% and Pfizer returned -20% in US dollars, so Johnson & Johnson has been the stronger performer in that window. Past performance says little about the future, which is why the chart on this page lets you check other periods too.
Can I buy both Johnson & Johnson and Pfizer shares?
Yes. Nothing stops you owning both companies, and many investors do exactly that instead of trying to pick the winner. Both are available to investors worldwide through a broker such as Interactive Brokers.
Is it safer to buy an ETF instead?
A broad index fund holds hundreds of companies at once, usually including both of these, so a single bad year at one business barely dents it. Owning individual shares concentrates that risk, which is why many beginners keep single stocks to a small slice of a mostly fund-based portfolio.